Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Student Precarity and Psychiatry (PEPSY)

torstai 11. kesäkuuta 2026 päivittänyt: Assistance Publique - Hôpitaux de Paris

Impact of Precarity on the Emergence of Psychiatric Disorders and the Use of Care Among Students

Since the COVID-19 pandemic, mental health disorders have increased significantly, particularly among young people. In France, the proportion of young people aged 18 to 25 suffering from depression almost doubled between 2017 and 2021. This phenomenon particularly affects students, who are already identified as being at greater risk of mental health disorders than the general population. Medical students seem to be particularly vulnerable: in 2021, a national study showed very high rates of depression and suicidal thoughts in this population. The main factor associated with depression was the feeling of financial hardship.

Students often face multiple forms of insecurity. Financially, they have limited resources and struggle to cover their basic needs such as housing, food and healthcare. Socially, many experience significant isolation, particularly when they are away from their families or under pressure from their studies. All of this has a significant impact on their mental health. Unfortunately, many students do not seek help due to lack of time, resources, or awareness of support services. The 2021 study showed that only one-third of medical students suffering from depression received appropriate treatment.

The aim of our study is to assess the impact of precariousness on the onset of psychiatric disorders and on the use or non-use of healthcare services.

Our study will involve nearly 45,000 students from PSL and UPC universities. It is based on a longitudinal cohort (via questionnaires) over three years. The aim is to identify precisely the different aspects of student precariousness (housing, transport, isolation, economic difficulties, etc.) and their link with psychological distress. The study will measure the extent of the phenomenon and identify modifiable factors that could be targeted by preventive measures. The results will enable us to better target preventive measures and propose concrete solutions to improve students' well-being and promote their success.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

The COVID-19 pandemic has led to an increase in depression, particularly among young people. The French health barometer, conducted every 4-5 years by Santé Publique France (SPF), found that the prevalence of major depressive episodes (MDE) among 18-25 year olds doubled (from 11.7% to 20.8%) between 2017 and 2021. There has also been an increase in suicidal thoughts and suicide attempts. Among students, data from the 2016 Student Life Observatory (OVE) found a higher prevalence of CDE and suicidal thoughts among students than in the general population of the same age. Among the factors associated with the risk of EDC, experiencing significant financial difficulties was the main one[4]. Among medical students, a national study conducted in 2021 found that the prevalence of depression and suicidal thoughts was much higher than in the general population of the same age. Financial difficulties were also the main factor associated with the risk of depression. Indeed, students are a population that is particularly vulnerable to precariousness due to several factors. Economically, they often have limited incomes, depending on parental support, insufficient grants or precarious jobs. This exposes them to difficulties in meeting their basic needs such as housing, food and healthcare. Socially, isolation can exacerbate their situation, especially when they are far from their family network or under pressure from their studies. In addition, high academic demands, combined with unstable living conditions, impact their mental health and can contribute to the development of psychiatric disorders, which often go untreated due to a lack of affordable and accessible resources. International students are even more vulnerable due to language and administrative barriers and limited access to local support services. This multidimensional precariousness highlights the need for comprehensive support for this population, even though students are unlikely to seek professional help. In the 2021 survey, only 32% of medical students suffering from depression received adequate care. If we want to improve the health of medical students, we must not only treat disorders, but also prevent them from occurring by helping students strive for a state of well-being. In terms of prevention, the Haute Autorité de Santé (HAS) distinguishes between three levels: primary prevention, which acts upstream of the disease (on risk factors); secondary prevention, which acts at an early stage of its development (screening); and tertiary prevention, which acts on complications and the risk of recurrence.

The objectives of the study are to identify and quantify the modifiable predictive and moderating factors explaining students' psychological distress that could give rise to (primary) prevention actions by studying the various components of precariousness (housing, transport, study conditions, social isolation, grants, etc.). It also aims to study the impact of the various components of precariousness on the use and non-use of healthcare (screening and treatment, secondary and tertiary prevention).

The data will be entered directly by participants on the SKEZIA platform (https://skezi.eu/) (a solution developed by SKEZI) co-founded by AP-HP and Paris-Cité University, and will be hosted on HDS-approved servers.

Main objective:

The objective is to explore the impact of precariousness on the risk of characterised depressive episodes and the use of healthcare among PSL students (17,000 students) and UPC health faculty students (28,000 students).

Primary outcome measure:

The study will assess the 12-month prevalence of:

  • characterised depressive episodes (using the Composite International Diagnostic Interview Short-Form (CIDI-SF)) and suicidal ideation in the same way as SPF and OVE;
  • use of healthcare services, which will be measured in a similar way to the OVE survey and the medical student survey.

Precariousness will be assessed by the question: 'Would you say that you are currently experiencing financial difficulties?'

Secondary objectives and evaluation criteria:

The secondary objectives are to :

  • evaluate the prevalence of :
  • anxiety, which will be assessed using the GAD7;
  • eating disorders, which will be assessed using the SCOFF;
  • alcohol addiction, which will be assessed using the AUDIT, and cannabis addiction, which will be assessed using the CAST;
  • burnout, using the student version, which will be assessed using the MBI-SS for pre-clinical or healthcare students and the MBI-HSS for externs and residents,
  • dropout, which will be assessed by a single question as in the CNA-CORE survey,
  • insomnia, which will be measured by the Insomnia Severity Index (ISI),
  • loneliness, which will be assessed using the UCLA 3 items,
  • harassment,
  • discriminatory treatment,
  • and quality of life (WHOQOL);
  • identify and quantify modifiable predictive and moderating factors explaining students' psychological distress that could lead to (primary) prevention measures = by studying the various components of precariousness (housing, transport, study conditions, social isolation, grants, etc.),
  • study the impact of the various components of precariousness on the use and non-use of healthcare (screening and treatment, secondary and tertiary prevention). This will be assessed using questions on the renunciation of healthcare and its causes.

Opintotyyppi

Havainnollistava

Ilmoittautuminen (Arvioitu)

45000

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

Tutki yhteystietojen varmuuskopiointi

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

  • Aikuinen
  • Vanhempi Aikuinen

Hyväksyy terveitä vapaaehtoisia

Joo

Näytteenottomenetelmä

Ei-todennäköisyysnäyte

Tutkimusväestö

All students enrolled at Paris Sciences et Lettres University or the Faculty of Health Sciences at Paris Cité University.

Kuvaus

Inclusion Criteria:

  • Student enrolled at Paris Sciences et Lettres University (PSL, 17,000 students) or the Faculty of Health Sciences at Paris Cité University (UPC, 28,000 students),
  • Aged 18 or over,
  • Fluent in French,
  • Affiliated to a health insurance.

Exclusion Criteria:

  • Applicants under the age of 18,
  • Not enrolled at PSL universities or the UPCS Faculty of Health,
  • Insufficient level of French.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

Kohortit ja interventiot

Ryhmä/Kohortti
Interventio / Hoito
Health students
All students enrolled at the Faculty of Health Sciences of Paris Cité University
Kyselylomakkeet
Non-health students
All students enrolled at Paris Sciences and Letters University
Kyselylomakkeet

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Composite International Diagnostic Interview Short-Form (CIDI-SF)
Aikaikkuna: Day 0
12-months prevalence Major Depressive Disorder and suicidal thoughts Composite International Diagnostic Interview Short-Form (CIDI-SF)
Day 0
Composite International Diagnostic Interview Short-Form (CIDI-SF)
Aikaikkuna: 12 months
12-months prevalence Major Depressive Disorder and suicidal thoughts Composite International Diagnostic Interview Short-Form (CIDI-SF)
12 months
Use of care
Aikaikkuna: Day 0
Use of care service of care professional
Day 0
Use of care
Aikaikkuna: 12 months
Use of care service of care professional
12 months
Precarity
Aikaikkuna: Day 0
Question "Would you say that you are currently experiencing financial difficulties?"
Day 0
Precarity
Aikaikkuna: 12 months
Question "Would you say that you are currently experiencing financial difficulties?"
12 months

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
GAD7
Aikaikkuna: Day 0
Prevalence of anxiety
Day 0
GAD7
Aikaikkuna: 12 months
Prevalence of anxiety
12 months
GAD7
Aikaikkuna: 24 months
Prevalence of anxiety
24 months
SCOFF
Aikaikkuna: Day 0
Prevalence of Eating disorders
Day 0
SCOFF
Aikaikkuna: 12 months
Prevalence of Eating disorders
12 months
SCOFF
Aikaikkuna: 24 months
Prevalence of Eating disorders
24 months
AUDIT
Aikaikkuna: Day 0
Prevalence of Alcohol addiction
Day 0
AUDIT
Aikaikkuna: 12 months
Prevalence of Alcohol addiction
12 months
AUDIT
Aikaikkuna: 24 months
Prevalence of Alcohol addiction
24 months
CAST
Aikaikkuna: Day 0
Prevalence of cannabis addiction
Day 0
CAST
Aikaikkuna: 12 months
Prevalence of cannabis addiction
12 months
CAST
Aikaikkuna: 24 months
Prevalence of cannabis addiction
24 months
MBI-SS or MBI-HSS
Aikaikkuna: Day 0
Prevalence of Burnout using the student version : will be assessed using the MBI-SS for pre-clinical students or caregivers or Prevalence of Burnout using the student version : will be assessed using the MBI-HSS for externs and residents
Day 0
MBI-SS or MBI-HSS
Aikaikkuna: 12 months
Prevalence of Burnout using the student version : will be assessed using the MBI-SS for pre-clinical students or caregivers or Prevalence of Burnout using the student version : will be assessed using the MBI-HSS for externs and residents Time Frame: D0
12 months
MBI-SS or MBI-HSS
Aikaikkuna: 24 months
Prevalence of Burnout using the student version : will be assessed using the MBI-SS for pre-clinical students or caregivers or Prevalence of Burnout using the student version : will be assessed using the MBI-HSS for externs and residents Time Frame: D0
24 months
A single question as in the CNA-CORE survey
Aikaikkuna: Day 0
Prevalence of Dropout: will be assessed using a single question as in the CNA-CORE survey
Day 0
A single question as in the CNA-CORE survey
Aikaikkuna: 12 months
Prevalence of Dropout: will be assessed using a single question as in the CNA-CORE survey
12 months
A single question as in the CNA-CORE survey
Aikaikkuna: 24 months
Prevalence of Dropout: will be assessed using a single question as in the CNA-CORE survey
24 months
Insomnia Severity Index (ISI)
Aikaikkuna: Day 0
Prevalence of Insomnia
Day 0
Insomnia Severity Index (ISI)
Aikaikkuna: 12 months
Prevalence of Insomnia
12 months
Insomnia Severity Index (ISI)
Aikaikkuna: 24 months
Prevalence of Insomnia
24 months
UCLA 3 items
Aikaikkuna: Day 0
Prevalence of Loneliness
Day 0
UCLA 3 items
Aikaikkuna: 12 months
Prevalence of Loneliness
12 months
UCLA 3 items
Aikaikkuna: 24 months
Prevalence of Loneliness
24 months
Questions about harrassment
Aikaikkuna: Day 0
Harrassment
Day 0
Questions about harrassment
Aikaikkuna: 12 months
Harrassment
12 months
Questions about harrassment
Aikaikkuna: 24 months
Harrassment
24 months
Questions about discriminatory treatment
Aikaikkuna: Day 0
Discriminatory treatment
Day 0
Questions about discriminatory treatment
Aikaikkuna: 12 months
Discriminatory treatment
12 months
Questions about discriminatory treatment
Aikaikkuna: 24 months
Discriminatory treatment
24 months
WHOQOL
Aikaikkuna: Day 0
Quality of life
Day 0
WHOQOL
Aikaikkuna: 12 months
Quality of life
12 months
WHOQOL
Aikaikkuna: 24 months
Quality of life
24 months
Components of precariousness
Aikaikkuna: Day 0
Predictive and moderating factors = by studying the different components of precariousness (housing, transport, study conditions, social isolation, grants, etc.).
Day 0
Components of precariousness
Aikaikkuna: 12 months
Predictive and moderating factors = by studying the different components of precariousness (housing, transport, study conditions, social isolation, grants, etc.).
12 months
Questions on the renunciation of healthcare and its causes.
Aikaikkuna: 12 months
Impact of the various components of precariousness on the use and non-use of healthcare will be assessed using questions on the renunciation of healthcare and its causes.
12 months
Components of precariousness
Aikaikkuna: 24 months
Predictive and moderating factors = by studying the different components of precariousness (housing, transport, study conditions, social isolation, grants, etc.).
24 months

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Arvioitu)

Tiistai 1. syyskuuta 2026

Ensisijainen valmistuminen (Arvioitu)

Perjantai 1. syyskuuta 2028

Opintojen valmistuminen (Arvioitu)

Keskiviikko 1. marraskuuta 2028

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Keskiviikko 4. maaliskuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Tiistai 26. toukokuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Maanantai 1. kesäkuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Maanantai 15. kesäkuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Torstai 11. kesäkuuta 2026

Viimeksi vahvistettu

Maanantai 1. kesäkuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa